Coagulation factors IX through XIII and the risk of future venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology

Blood

Volumn 114, Issue 14, 2009, Pages 2878-2883

  Cushman, Mary ^a   O'Meara, Ellen S ^b   Folsom, Aaron R ^c   Heckbert, Susan R ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 9;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; DIABETES MELLITUS; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; RISK; RISK ASSESSMENT; RISK FACTOR; SEX; THROMBOEMBOLISM; THROMBOSIS; VEIN THROMBOSIS;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FACTOR IX; FACTOR X; FACTOR XI; FACTOR XII; FACTOR XIII; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 70449472262     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-219915     Document Type: Article

References (33)

1. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62-69. (Pubitemid 46553809)
2. van Hylckama Vlieg A, ven der Linden I, Bertina R, Rosendaal F. High levels of factor IX increase the risk of venous thrombosis. Blood. 2000;95(12):3678-3682.
3. de Visser MC, Poort SR, Vos HL, Rosendaal FR, Bertina RM. Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis. Thromb Haemost. 2001;85(6):1011-1017. (Pubitemid 32573752)
4. Meijers JC, Tekelenberg WL, Bouma BN, Bertina RM, Rosendaal FR. High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med. 2000;342(10):696-701. (Pubitemid 30131422)
5. Koster T, Rosendaal FR, Briet E, Vandenbroucke JP. John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study. Br J Haematol. 1994;87(2):422-424. (Pubitemid 24204755)
6. Halbmayer WM, Mannhalter C, Feichtinger C, Rubi K, Fischer M. The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism. Thromb Haemost. 1992;68(3):285-290.
7. Tirado I, Soria JM, Mateo J, et al. Association after linkage analysis indicates that homozygosity for the 46C → T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost. 2004;91(5):899-904. (Pubitemid 38647492)
8. Gallimore MJ, Harris SL, Jones DW, Winter M. Plasma levels of factor XII, prekallikrein and high molecular weight kininogen in normal blood donors and patients having suffered venous thrombosis. Thromb Res. 2004;114(2):91-96. (Pubitemid 39089093)
9. Cochery-Nouvellon E, Mercier E, Lissalde-Lavigne G, et al. Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy. J Thromb Haemost. 2007;5(4):700-707. (Pubitemid 46563567)
10. Wells PS, Anderson JL, Scarvelis DK, Doucette SP, Gagnon F. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis. Am J Epidemiol. 2006;164(2):101-109. (Pubitemid 43992174)
11. Cushman M, Cornell A, Folsom AR, et al. Associations of the beta-fibrinogen Hae III and factor XIII Val34Leu gene variants with venous thrombosis. Thromb Res. 2007;121(3):339-345.
12. Lowe GD, Haverkate F, Thompson SG, et al. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis. Thromb Haemost. 1999;81(6):879-886. (Pubitemid 29312701)
13. Heit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program. 2007;127-135.
14. Tsai AW, Cushman M, Rosamond WD, et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med. 2002;113(8):636-642. (Pubitemid 36015799)
15. Ohira T, Cushman M, Tsai MY, et al. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost. 2007;5(7):1455-1461. (Pubitemid 46965375)
16. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the Longitudinal Investigation of Thromboembolism Etiology. Am J Med. 2004;117(1):19-25. (Pubitemid 38801482)
17. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: design and rationale. Ann Epidemiol. 1991;1(3):263-276.
18. Atherosclerosis Risk in Communities. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol. 1989;129(4):687-702.
19. Chambless L, McMahon R, Finch A, et al. ARIC Hemostasis Study III: quality control. Thromb Haemost. 1993;70(4):588-594. (Pubitemid 23310562)
20. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem. 1995;42(2):264-270.
21. Cushman M, Folsom AR, Wang L, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood. 2003;101(4):1243-1248. (Pubitemid 36182491)
22. Rothman KJ, Greenland S. Modern Epidemiology. Philadelphia, PA: Lippincott-Raven; 1998.
23. Assmann SF, Hosmer DW, Lemeshow S, Mundt KA. Confidence intervals for measures of interaction. Epidemiology. 1996;7(3):286-290.
24. Smith NL, Hindorff LA, Heckbert SR, et al. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA. 2007;297(5):489-498.
25. Bezemer ID, Bare LA, Doggen CJ, et al. Gene variants associated with deep vein thrombosis. JAMA. 2008;299(11):1306-1314.
26. von dem Borne PA, Cox LM, Bouma BN. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor. Blood Coagul Fibrinolysis. 2006;17(4):251-257.
27. van Minkelen R, de Visser MC, van Hylckama Vlieg A, Vos HL, Bertina RM. Sequence variants and haplotypes of the factor IX gene and the risk of venous thrombosis. J Thromb Haemost. 2008;6(9):1610-1613.
28. Ratnoff OD, Busse RJ, Shean RP. The demise of John Hageman. N Engl J Med. 1968;279:760-761.
29. Mandle RJ Jr, Kaplan AP. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen. Blood. 1979;54(4):850-862.
30. Kanaji T, Watanabe K, Hattori S, et al. Factor XII gene (F12)-4C/C polymorphism in combination with low protein S activity is associated with deep vein thrombosis. Thromb Haemost. 2006;96(6):854-855. (Pubitemid 44883831)
31. Bertina RM, Poort SR, Vos HL, Rosendaal FR. The 46C → T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis. J Thromb Haemost. 2005;3(3):597-599. (Pubitemid 41632890)
32. van Hylckama Vlieg A, Komanasin N, Ariens RA, et al. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol. 2002;119(1):169-175. (Pubitemid 35176517)
33. Komanasin N, Catto AJ, Futers TS, et al. A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis. J Thromb Haemost. 2005;3(11):2487-2496. (Pubitemid 41727166)